Skip to main content
PMC home page
Tobacco Control logoLink to Tobacco Control
. 2000 Sep;9(Suppl 3):iii91–iii94. doi: 10.1136/tc.9.suppl_3.iii91

The use of pharmacotherapies for smoking cessation during pregnancy

N Benowitz, D Dempsey, R Goldenberg, J Hughes, P Dolan-Mullen, P Ogburn, C Oncken, C Orleans, T Slotkin, H Whiteside, S Yaffe
PMCID: PMC1766294  PMID: 10982920

Full Text

The Full Text of this article is available as a PDF (113.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benowitz N. L., Gourlay S. G. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997 Jun;29(7):1422–1431. doi: 10.1016/s0735-1097(97)00079-x. [DOI] [PubMed] [Google Scholar]
  2. Benowitz N. L. Nicotine replacement therapy during pregnancy. JAMA. 1991 Dec 11;266(22):3174–3177. [PubMed] [Google Scholar]
  3. Hughes J. R., Goldstein M. G., Hurt R. D., Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA. 1999 Jan 6;281(1):72–76. doi: 10.1001/jama.281.1.72. [DOI] [PubMed] [Google Scholar]
  4. Joseph A. M., Norman S. M., Ferry L. H., Prochazka A. V., Westman E. C., Steele B. G., Sherman S. E., Cleveland M., Antonuccio D. O., Antonnucio D. O. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996 Dec 12;335(24):1792–1798. doi: 10.1056/NEJM199612123352402. [DOI] [PubMed] [Google Scholar]
  5. Marks J. S., Koplan J. P., Hogue C. J., Dalmat M. E. A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am J Prev Med. 1990 Sep-Oct;6(5):282–289. [PubMed] [Google Scholar]
  6. Mullen P. D. Maternal smoking during pregnancy and evidence-based intervention to promote cessation. Prim Care. 1999 Sep;26(3):577–589. doi: 10.1016/s0095-4543(05)70118-4. [DOI] [PubMed] [Google Scholar]
  7. Ogburn P. L., Jr, Hurt R. D., Croghan I. T., Schroeder D. R., Ramin K. D., Offord K. P., Moyer T. P. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 1999 Sep;181(3):736–743. doi: 10.1016/s0002-9378(99)70521-1. [DOI] [PubMed] [Google Scholar]
  8. Oncken C. A., Hardardottir H., Hatsukami D. K., Lupo V. R., Rodis J. F., Smeltzer J. S. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol. 1997 Oct;90(4 Pt 1):569–574. doi: 10.1016/s0029-7844(97)00309-8. [DOI] [PubMed] [Google Scholar]
  9. Oncken C. A., Hatsukami D. K., Lupo V. R., Lando H. A., Gibeau L. M., Hansen R. J. Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther. 1996 Jun;59(6):654–661. doi: 10.1016/S0009-9236(96)90005-3. [DOI] [PubMed] [Google Scholar]
  10. Raw M., McNeill A., West R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax. 1998 Dec;53 (Suppl 5 Pt 1):S1–19. doi: 10.1136/thx.53.2008.s1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Slotkin T. A. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther. 1998 Jun;285(3):931–945. [PubMed] [Google Scholar]
  12. Wright L. N., Thorp J. M., Jr, Kuller J. A., Shrewsbury R. P., Ananth C., Hartmann K. Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. Am J Obstet Gynecol. 1997 May;176(5):1090–1094. doi: 10.1016/s0002-9378(97)70407-1. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES